Craig Hettenbach
Stock Analyst at Morgan Stanley
(2.17)
# 2,689
Out of 4,854 analysts
291
Total ratings
57.35%
Success rate
-1.14%
Average return
Main Sectors:
Stocks Rated by Craig Hettenbach
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VEEV Veeva Systems | Maintains: Underweight | $201 → $210 | $285.36 | -26.41% | 8 | May 29, 2025 | |
| THC Tenet Healthcare | Maintains: Overweight | $165 → $175 | $171.46 | +2.06% | 2 | May 5, 2025 | |
| HIMS Hims & Hers Health | Maintains: Equal-Weight | $60 → $40 | $56.33 | -28.99% | 3 | Apr 29, 2025 | |
| UHS Universal Health Services | Initiates: Equal-Weight | $200 | $189.39 | +5.60% | 1 | Mar 26, 2025 | |
| ARDT Ardent Health | Maintains: Overweight | $24 → $22 | $14.86 | +48.05% | 2 | Jan 21, 2025 | |
| AMWL American Well | Maintains: Equal-Weight | $20 → $11 | $6.96 | +50.86% | 5 | Dec 17, 2024 | |
| GDRX GoodRx Holdings | Maintains: Equal-Weight | $7 → $6 | $4.08 | +47.06% | 2 | Dec 17, 2024 | |
| HCA HCA Healthcare | Maintains: Equal-Weight | $406 → $355 | $384.34 | -7.63% | 2 | Dec 17, 2024 | |
| SLAB Silicon Laboratories | Maintains: Equal-Weight | $123 → $97 | $126.62 | -23.39% | 14 | Nov 5, 2024 | |
| DH Definitive Healthcare | Maintains: Equal-Weight | $9 → $5 | $3.74 | +33.87% | 12 | Aug 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $96 → $114 | $71.59 | +59.24% | 24 | Feb 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $62 → $57 | $27.03 | +110.88% | 19 | Jun 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $85 → $81 | $65.25 | +24.14% | 23 | Jun 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $55 → $35 | $58.85 | -40.53% | 4 | May 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $20 → $18 | $15.42 | +16.73% | 4 | Mar 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $208 → $185 | $78.58 | +135.43% | 23 | Feb 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $162 → $167 | $164.65 | +1.43% | 23 | Jan 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $42 → $42 | $93.36 | -55.01% | 25 | Jan 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $165 → $159 | $174.34 | -8.80% | 2 | Dec 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $115 → $125 | $63.58 | +96.60% | 3 | Dec 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $57 → $72 | $246.93 | -70.72% | 22 | Dec 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $193 → $195 | $192.42 | +1.34% | 3 | Oct 27, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $515 → $488 | $303.22 | +60.94% | 1 | Aug 31, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $297 → $296 | $296.88 | -0.30% | 1 | Aug 31, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $273 → $368 | $253.97 | +44.90% | 1 | Aug 31, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $500 → $513 | $230.70 | +122.37% | 1 | Aug 31, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $321 → $275 | $312.18 | -11.91% | 1 | Aug 31, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $94 → $88 | $55.16 | +59.54% | 1 | Aug 31, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Equal-Weight | n/a | $50.17 | - | 11 | Aug 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $173 → $185 | $62.56 | +195.74% | 2 | May 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $190 → $213 | $207.68 | +2.56% | 19 | Apr 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $53 → $58 | $113.45 | -48.88% | 12 | Feb 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $101 → $117 | $222.26 | -47.36% | 15 | Jun 16, 2020 |
Veeva Systems
May 29, 2025
Maintains: Underweight
Price Target: $201 → $210
Current: $285.36
Upside: -26.41%
Tenet Healthcare
May 5, 2025
Maintains: Overweight
Price Target: $165 → $175
Current: $171.46
Upside: +2.06%
Hims & Hers Health
Apr 29, 2025
Maintains: Equal-Weight
Price Target: $60 → $40
Current: $56.33
Upside: -28.99%
Universal Health Services
Mar 26, 2025
Initiates: Equal-Weight
Price Target: $200
Current: $189.39
Upside: +5.60%
Ardent Health
Jan 21, 2025
Maintains: Overweight
Price Target: $24 → $22
Current: $14.86
Upside: +48.05%
American Well
Dec 17, 2024
Maintains: Equal-Weight
Price Target: $20 → $11
Current: $6.96
Upside: +50.86%
GoodRx Holdings
Dec 17, 2024
Maintains: Equal-Weight
Price Target: $7 → $6
Current: $4.08
Upside: +47.06%
HCA Healthcare
Dec 17, 2024
Maintains: Equal-Weight
Price Target: $406 → $355
Current: $384.34
Upside: -7.63%
Silicon Laboratories
Nov 5, 2024
Maintains: Equal-Weight
Price Target: $123 → $97
Current: $126.62
Upside: -23.39%
Definitive Healthcare
Aug 6, 2024
Maintains: Equal-Weight
Price Target: $9 → $5
Current: $3.74
Upside: +33.87%
Feb 7, 2023
Maintains: Equal-Weight
Price Target: $96 → $114
Current: $71.59
Upside: +59.24%
Jun 10, 2022
Maintains: Overweight
Price Target: $62 → $57
Current: $27.03
Upside: +110.88%
Jun 10, 2022
Maintains: Overweight
Price Target: $85 → $81
Current: $65.25
Upside: +24.14%
May 18, 2022
Maintains: Equal-Weight
Price Target: $55 → $35
Current: $58.85
Upside: -40.53%
Mar 28, 2022
Maintains: Overweight
Price Target: $20 → $18
Current: $15.42
Upside: +16.73%
Feb 3, 2022
Maintains: Overweight
Price Target: $208 → $185
Current: $78.58
Upside: +135.43%
Jan 27, 2022
Maintains: Equal-Weight
Price Target: $162 → $167
Current: $164.65
Upside: +1.43%
Jan 27, 2022
Maintains: Equal-Weight
Price Target: $42 → $42
Current: $93.36
Upside: -55.01%
Dec 17, 2021
Maintains: Equal-Weight
Price Target: $165 → $159
Current: $174.34
Upside: -8.80%
Dec 13, 2021
Maintains: Overweight
Price Target: $115 → $125
Current: $63.58
Upside: +96.60%
Dec 10, 2021
Maintains: Overweight
Price Target: $57 → $72
Current: $246.93
Upside: -70.72%
Oct 27, 2021
Maintains: Underweight
Price Target: $193 → $195
Current: $192.42
Upside: +1.34%
Aug 31, 2021
Maintains: Overweight
Price Target: $515 → $488
Current: $303.22
Upside: +60.94%
Aug 31, 2021
Maintains: Overweight
Price Target: $297 → $296
Current: $296.88
Upside: -0.30%
Aug 31, 2021
Maintains: Overweight
Price Target: $273 → $368
Current: $253.97
Upside: +44.90%
Aug 31, 2021
Maintains: Overweight
Price Target: $500 → $513
Current: $230.70
Upside: +122.37%
Aug 31, 2021
Maintains: Overweight
Price Target: $321 → $275
Current: $312.18
Upside: -11.91%
Aug 31, 2021
Maintains: Overweight
Price Target: $94 → $88
Current: $55.16
Upside: +59.54%
Aug 3, 2021
Upgrades: Equal-Weight
Price Target: n/a
Current: $50.17
Upside: -
May 7, 2021
Maintains: Overweight
Price Target: $173 → $185
Current: $62.56
Upside: +195.74%
Apr 8, 2021
Downgrades: Equal-Weight
Price Target: $190 → $213
Current: $207.68
Upside: +2.56%
Feb 11, 2021
Maintains: Equal-Weight
Price Target: $53 → $58
Current: $113.45
Upside: -48.88%
Jun 16, 2020
Maintains: Equal-Weight
Price Target: $101 → $117
Current: $222.26
Upside: -47.36%